Luke Nolan
Impact in
-
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
-
- Cell Adhesion Molecules Research
Papers in
- Oncology 6
- Lung Cancer Research Studies 4
- Pancreatic and Hepatic Oncology Research 1
-
- Autoimmune Neurological Disorders and Treatments 2
- Neuroblastoma Research and Treatments 2
- Co-authors
- Edurne Arriola (4 shared papers)Christian H. Ottensmeier (5 shared papers)Richard W. Griffiths (2 shared papers)Sarah Danson (2 shared papers)Matthew Wheater (3 shared papers)Dean A. Fennell (4 shared papers)Anna K. Nowak (2 shared papers)David Gilligan (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)British Journal of Urology (2 papers)Chemotherapy (1 paper)Neuropathology and Applied Neurobiology (1 paper)The Breast (1 paper)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Luke Nolan
13 papers receiving 323 citations
Peers
Comparison fields: 5 of 50
- Oncology 180
- Immunology and Allergy 21
- Pulmonary and Respiratory Medicine 94
- Biotechnology 27
- Epidemiology 57
Countries citing papers authored by Luke Nolan
This map shows the geographic impact of Luke Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Nolan more than expected).
Fields of papers citing papers by Luke Nolan
This network shows the impact of papers produced by Luke Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Nolan. The network helps show where Luke Nolan may publish in the future.
Co-authors
The 25 scholars most cited alongside Luke Nolan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 99 | |
| 2 | 2019 | 90 | |
| 3 | 2019 | 67 | |
| 4 | 2011 | 11 | |
| 5 | 2010 | 10 | |
| 6 | 2017 | 9 | |
| 7 | 2021 | 8 | |
| 8 | 2014 | 8 | |
| 9 | 2010 | 7 | |
| 10 | 2023 | 5 | |
| 11 | 2012 | 5 | |
| 12 | The Aircraft Leasing Industry in Ireland: Cross Border Flows and Statistical Treatment | 2017 | 4 |
| 13 | 2021 | 3 |
About Luke Nolan
Luke Nolan is a scholar working on Oncology, Neurology, Biotechnology, Surgery and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 326 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), Cancer Research and Treatments (3 papers), Autoimmune Neurological Disorders and Treatments (2 papers), Neuroblastoma Research and Treatments (2 papers), Testicular diseases and treatments (2 papers), Virus-based gene therapy research (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Aviation Industry Analysis and Trends (1 paper). The work is most often cited by research in Oncology (180 citations), Immunology and Allergy (21 citations), Pulmonary and Respiratory Medicine (94 citations), Biotechnology (27 citations) and Epidemiology (57 citations). Luke Nolan has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Edurne Arriola, Christian H. Ottensmeier, Richard W. Griffiths, Sarah Danson, Matthew Wheater, Dean A. Fennell, Anna K. Nowak, David Gilligan, Judith Cave and Paul Taylor. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Urology, Chemotherapy, Neuropathology and Applied Neurobiology and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.